keyword
https://read.qxmd.com/read/38669559/colonoscopy-and-subsequent-risk-of-parkinson-s-disease
#1
JOURNAL ARTICLE
Anna-Victoria Holtz, Anne Fink, Gültekin Tamgüney, Gabriele Doblhammer
BACKGROUND: Parkinson's disease (PD) is caused by the misfolding and aggregation of α-synuclein in neurons into toxic oligomers and fibrils that have prion-like properties allowing them to infect healthy neurons and to be transmitted to animal models of PD by injection or oral exposure. Given α-synuclein fibrils' potential transmission on the gut-brain axis, α-synuclein may be transmitted through colonoscopy procedures. OBJECTIVE: This study examines a possible association between colonoscopy and PD...
April 24, 2024: Journal of Parkinson's Disease
https://read.qxmd.com/read/38669367/causal-relationships-between-gut-microbrome-and-digestive-system-diseases-a-two-sample-mendelian-randomization-study
#2
JOURNAL ARTICLE
Wenjing Ding, Liangliang Chen, Jianguo Xia, Gang Dong, Biao Song, Bei Pei, Xuejun Li
Growing evidences of recent studies have shown that gut microbrome are causally related to digestive system diseases (DSDs). However, causal relationships between the gut microbiota and the risk of DSDs still remain unclear. We utilized identified gut microbiota based on class, family, genus, order and phylum information and digestive system diseases genome-wide association study (GWAS) dataset for two-sample Mendelian randomization (MR) analysis. The inverse variance weighted (IVW) method was used to evaluate causal relationships between gut microbiota and 7 DSDs, including chronic gastritis, colorectal cancer, Crohn's disease, gastric cancer, gastric ulcer, irritable bowel syndrome and esophageal cancer...
April 26, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38669265/epithelial-mesenchymal-interaction-protects-normal-colonocytes-from-4-hne-induced-phenotypic-transformation
#3
JOURNAL ARTICLE
Jacques Dupuy, Emma Cogo, Edwin Fouché, Françoise Guéraud, Fabrice Pierre, Pascale Plaisancié
INTRODUCTION: Recent studies have shown that epithelial-stromal interactions could play a role in the development of colorectal cancer. Here, we investigated the role of fibroblasts in the transformation of normal colonocytes induced by 4-HNE. METHODS: Normal Co colonocytes and nF fibroblasts from the same mouse colon were exposed, in monoculture (m) or coculture (c), to 4-HNE (5 μM) twice weekly for 3 weeks. Gene expression was then analysed and the ability of Co colonocytes to grow in anchorage-independent conditions was tested in soft agar...
2024: PloS One
https://read.qxmd.com/read/38669154/association-of-cardiovascular-health-and-educational-status-in-a-screening-cohort
#4
JOURNAL ARTICLE
Sarah Wernly, Georg Semmler, Maria Flamm, Andreas Völkerer, Ralf Erkens, Elmar Aigner, Christian Datz, Bernhard Wernly
INTRODUCTION: The global burden of chronic diseases, including cardiovascular disease, remains a significant public health challenge. The Life's Simple 7 (LS7) score was developed as a tool to evaluate cardiovascular health behaviours and habits and identify high-risk individuals. The present study aimed to assess the distribution of LS7 scores among educational strata. METHODS: The study population consisted of 3,383 asymptomatic individuals screened for colorectal cancer at a single centre in Austria...
March 2024: Central European Journal of Public Health
https://read.qxmd.com/read/38668994/colonoscopic-cancer-detection-rate-a-new-performance-measure-is-it-fit-for-purpose
#5
JOURNAL ARTICLE
Khalid Bashir, Iosif Beintaris, Linda Sharp, Julia Newton, Katherine Elliott, Jon Rees, Peter Rogers, Matt Rutter
INTRODUCTION: Gastrointestinal symptoms correlate poorly with cancer diagnosis. A faecal immunochemical test (FIT) result of ≥10 µg has high sensitivity and negative predictive value for colorectal cancer (CRC) detection. An FIT-based diagnostic pathway may lead to more effective resource utilisation. We aimed to use National Endoscopy Database (NED) data to create a new colonoscopy performance measure, cancer detection rate (CDR) to assess the appropriate identification of target populations for colonoscopy; then to use CDR to assess the impact of implementing an FIT-based referral pathway locally...
May 2024: Frontline Gastroenterology
https://read.qxmd.com/read/38668989/fit-negative-clinic-as-a-safety-net-for-low-risk-patients-with-colorectal-cancer-impact-on-endoscopy-and-radiology-utilisation-a-retrospective-cohort-study
#6
JOURNAL ARTICLE
Gaurav B Nigam, Laween Meran, Ishita Bhatnagar, Sarah Evans, Reem Malik, Nicole Cianci, Julia Pakpoor, Charis Manganis, Brian Shine, Tim James, Brian D Nicholson, James E East, Rebecca M Palmer
BACKGROUND: Faecal immunochemical testing (FIT) is recommended by the National Institute for Health and Care Excellence to triage symptomatic primary care patients who have unexplained symptoms but do not meet the criteria for a suspected lower gastrointestinal cancer pathway. During the COVID-19 pandemic, FIT was used to triage patients referred with urgent 2-week wait (2ww) cancer referrals instead of a direct-to-test strategy. FIT-negative patients were assessed and safety netted in a FIT negative clinic...
May 2024: Frontline Gastroenterology
https://read.qxmd.com/read/38668983/fit-for-the-future
#7
JOURNAL ARTICLE
Robert Logan, Charles Andrews
No abstract text is available yet for this article.
May 2024: Frontline Gastroenterology
https://read.qxmd.com/read/38668912/a-systematic-review-of-cognitive-impairment-in-individuals-with-colorectal-cancer
#8
JOURNAL ARTICLE
Ye Wang, Zhiming Wang, Rongyu Li, Zheng Sun, Yi Zhang, Qiuping Li
PROBLEM IDENTIFICATION: Patients with colorectal cancer (CRC) encounter varying degrees of objective and subjective cognitive impairment. The prevalence of objective and subjective cognitive impairment, factors affecting cognitive impairment, and interventions are presented in this review. LITERATURE SEARCH: The CINAHL Plus®, Cochrane Library, Embase®, PsycINFO®, PubMed®, and CNKI databases were systematically searched from the time of the database's establishment to May 2023...
April 18, 2024: Oncology Nursing Forum
https://read.qxmd.com/read/38668897/prognostic-factors-in-pulmonary-metastases-resection-from-colorectal-cancer-impact-of-right-sided-colon-cancer-and-early-recurrence
#9
JOURNAL ARTICLE
Yo Tsukamoto, Takeo Nakada, Rintaro Shigemori, Daiki Kato, Takamasa Shibazaki, Shohei Mori, Makoto Odaka, Takashi Ohtsuka
OBJECTIVE: This retrospective cohort study aimed to explore the surgical outcomes and prognostic factors of resection of pulmonary metastases (PM) from colorectal cancer (CRC). METHODS: Overall, 60 patients who underwent resection of PM from CRC between 2015 and 2021 at two institutions were reviewed. The primary outcome were overall survival (OS) and early recurrence after PM resection. The association between OS and right-sided colon cancer (RCC) was investigated...
April 26, 2024: General Thoracic and Cardiovascular Surgery
https://read.qxmd.com/read/38668822/fasting-hyperglycaemia-and-fatty-liver-drive-colorectal-cancer-a-retrospective-analysis-in-1145-patients
#10
JOURNAL ARTICLE
Lucilla Crudele, Carlo De Matteis, Fabio Novielli, Stefano Petruzzelli, Ersilia Di Buduo, Giusi Graziano, Marica Cariello, Elena Piccinin, Raffaella Maria Gadaleta, Antonio Moschetta
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the hepatic manifestation of increased adiposopathy, whose pathogenetic features have been proposed as tumourigenic triggers for colorectal cancer (CRC). We aim to identify specific metabolic signatures involved in CRC development that may be used as non-invasive biomarkers, paving the way for specific and personalized strategies of CRC prevention and early detection. METHODS: We retrospectively assessed CRC onset during a time frame of 8 years in a cohort of 1145 out-patients individuals who had previously been evaluated for Metabolic Syndrome...
April 26, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38668817/targeting-dectin-1-and-or-vista-enhances-anti-tumor-immunity-in-melanoma-but-not-colorectal-cancer-model
#11
JOURNAL ARTICLE
Siavash Mashhouri, Amirhossein Rahmati, Ako Azimi, Roy A Fava, Ismail Hassan Ismail, John Walker, Shokrollah Elahi
PURPOSE: Acquired resistance to immune checkpoint blockers (ICBs) is a major barrier in cancer treatment, emphasizing the need for innovative strategies. Dectin-1 (gene Clec7a) is a C-type lectin receptor best known for its ability to recognize β-glucan-rich structures in fungal cell walls. While Dectin-1 is expressed in myeloid cells and tumor cells, its significance in cancer remains the subject of controversy. METHODS: Using Celc7a-/- mice and curdlan administration to stimulate Dectin-1 signaling, we explored its impact...
April 26, 2024: Cellular Oncology (Dordrecht)
https://read.qxmd.com/read/38668714/do-you-bleed-a-1-year-fobt-case-series-study
#12
JOURNAL ARTICLE
Spyridon Zouridis, Daniel Sofia, Osama Alshakhatreh, Madeline Cleary, Omar Daghstani, Paul J Feustel, Maheep Sangha, Seth Richter
GOALS: The goal of this study is to investigate fecal occult blood test's (FOBT) usage in cases of suspected gastrointestinal bleeding and how it may affect hospitalization length and inpatient endoscopy procedures. BACKGROUND: FOBT is an approved modality used in colorectal cancer screening but is often used inappropriately for the investigation of suspected gastrointestinal bleeding (GIB) in the hospital setting. The efficiency of FOBT when used for this purpose is questionable...
April 29, 2024: Journal of Clinical Gastroenterology
https://read.qxmd.com/read/38668684/ginsenoside-rg1-induces-autophagy-in-colorectal-cancer-through-inhibition-of-the-akt-mtor-p70s6k-pathway
#13
JOURNAL ARTICLE
Ruiqi Liu, Bin Zhang, Shuting Zou, Li Cui, Lin Lin, Lingchang Li
This study aimed to elucidate the anti-colon cancer mechanism of ginsenoside Rg1 in vitro and in vivo. Cell viability rate was detected using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) tetrazolium assay. The inhibitory effect of ginsenoside Rg1 against CT26 cell proliferation gradually increased with increasing concentration. The in vivo experiments also demonstrated an antitumor effect. The monodansylcadaverine (MDC), transmission electron microscopy (TEM), and expression of autophagy marker proteins confirmed that ginsenoside Rg1 induced autophagy in vitro...
April 28, 2024: Journal of Microbiology and Biotechnology
https://read.qxmd.com/read/38668664/colosplenic-fistula-diagnosis-and-management-a-case-series-and-review-of-literature
#14
JOURNAL ARTICLE
Oscar Hernandez Dominguez, Eddy P Lincango, Rebecca Spivak, Federico Almonacid-Cardenas, Christopher Prien, Tairin Uchino, Anna Spivak, Tracy L Hull, Scott R Steele, Stefan D Holubar
BACKGROUND: A colosplenic fistula (CsF) is an extremely rare complication. Its diagnosis and management remain poorly understood, owing to its infrequent incidence. Our objective was to systematically review the etiology, clinical features, diagnosis, management, and prognosis to help clinicians gain a better understanding of this unusual complication and provide aid if it is to be encountered. METHODS: A systematic review of studies reporting CsF diagnosis in Ovid MEDLINE, Ovid EMBASE, Scopus, Web of Science, and Wiley Cochrane Library from 1946 to June 2022...
April 1, 2024: International Journal of Surgery
https://read.qxmd.com/read/38668076/the-impact-of-the-pandemic-on-the-quality-of-colorectal-and-anal-cancer-care-and-2-year-clinical-outcomes
#15
JOURNAL ARTICLE
Melanie Powis, Rinku Sutradhar, Simron Singh, Shabbir Alibhai, Saidah Hack, Abed Baiad, Kevin Chen, Huaqi Li, Zuhal Mohmand, Monika K Krzyzanowska
We undertook a retrospective study to compare the quality of care delivered to a cohort of newly diagnosed adults with colon, rectal or anal cancer during the early phase of COVID-19 (02/20-12/20) relative to the same period in the year prior (the comparator cohort), and examine the impact of the pandemic on 2-year disease progression and all-cause mortality. We observed poorer performance on a number of quality measures, such as approximately three times as many patients in the COVID-19 cohort experienced 30-day post-surgical readmission (10...
April 19, 2024: Current Oncology
https://read.qxmd.com/read/38668065/prehabilitation-in-adults-undergoing-cancer-surgery-a-comprehensive-review-on-rationale-methodology-and-measures-of-effectiveness
#16
REVIEW
Carlos E Guerra-Londono, Juan P Cata, Katherine Nowak, Vijaya Gottumukkala
Cancer surgery places a significant burden on a patients' functional status and quality of life. In addition, cancer surgery is fraught with postoperative complications, themselves influenced by a patient's functional status. Prehabilitation is a unimodal or multimodal strategy that aims to increase a patient's functional capacity to reduce postoperative complications and improve postoperative recovery and quality of life. In most cases, it involves exercise, nutrition, and anxiety-reducing interventions. The impact of prehabilitation has been explored in several types of cancer surgery, most commonly colorectal and thoracic...
April 9, 2024: Current Oncology
https://read.qxmd.com/read/38668061/symptom-burden-and-time-from-symptom-onset-to-cancer-diagnosis-in-patients-with-early-onset-colorectal-cancer-a-multicenter-retrospective-analysis
#17
MULTICENTER STUDY
Victoria A Baronas, Arif A Arif, Eric Bhang, Gale K Ladua, Carl J Brown, Fergal Donnellan, Sharlene Gill, Heather C Stuart, Jonathan M Loree
Background : The incidence of colorectal cancer (CRC) is decreasing in individuals >50 years due to organised screening but has increased for younger individuals. We characterized symptoms and their timing before diagnosis in young individuals. Methods : We identified all patients diagnosed with CRC between 1990-2017 in British Columbia, Canada. Individuals <50 years ( n = 2544, EoCRC) and a matched cohort >50 ( n = 2570, LoCRC) underwent chart review to identify CRC related symptoms at diagnosis and determine time from symptom onset to diagnosis...
April 8, 2024: Current Oncology
https://read.qxmd.com/read/38667800/meroterpenoids-from-marine-sponge-hyrtios-sp-and-their-anticancer-activity-against-human-colorectal-cancer-cells
#18
JOURNAL ARTICLE
Jie Wang, Yue-Lu Yan, Xin-Yi Yu, Jia-Yan Pan, Xin-Lian Liu, Li-Li Hong, Bin Wang
Two new meroterpenoids, hyrtamide A ( 1 ) and hyrfarnediol A ( 2 ), along with two known ones, 3-farnesyl-4-hydroxybenzoic acid methyl ester ( 3 ) and dictyoceratin C ( 4 ), were isolated from a South China Sea sponge Hyrtios sp. Their structures were elucidated by NMR and MS data. Compounds 2 - 4 exhibited weak cytotoxicity against human colorectal cancer cells (HCT-116), showing IC50 values of 41.6, 45.0, and 37.3 μM, respectively. Furthermore, compounds 3 and 4 significantly suppressed the invasion of HCT-116 cells while also downregulating the expression of vascular endothelial growth factor receptor 1 (VEGFR-1) and vimentin proteins, which are key markers associated with angiogenesis and epithelial-mesenchymal transition (EMT)...
April 19, 2024: Marine Drugs
https://read.qxmd.com/read/38667537/impact-of-systemic-treatments-on-outcomes-and-quality-of-life-in-patients-with-ras-positive-stage-iv-colorectal-cancer-a-systematic-review
#19
REVIEW
Vlad Braicu, Pantea Stelian, Lazar Fulger, Gabriel Verdes, Dan Brebu, Ciprian Duta, Camelia Fizedean, Flavia Ignuta, Alexandra Ioana Danila, Gabriel Veniamin Cozma
This systematic review critically evaluates the impact of systemic treatments on outcomes and quality of life (QoL) in patients with RAS-positive stage IV colorectal cancer, with studies published up to December 2023 across PubMed, Scopus, and Web of Science. From an initial pool of 1345 articles, 11 relevant studies were selected for inclusion, encompassing a diverse range of systemic treatments, including panitumumab combined with FOLFOX4 and FOLFIRI, irinotecan paired with panitumumab, regorafenib followed by cetuximab ± irinotecan and vice versa, and panitumumab as a maintenance therapy post-induction...
April 20, 2024: Diseases (Basel)
https://read.qxmd.com/read/38667524/sexual-functioning-and-impact-on-quality-of-life-in-patients-with-early-onset-colorectal-cancer-a-systematic-review
#20
REVIEW
Catalin Vladut Ionut Feier, Ionut Andrei Paunescu, Alaviana Monique Faur, Gabriel Veniamin Cozma, Andiana Roxana Blidari, Calin Muntean
This systematic review investigates the intersection of early-onset colorectal cancer (EOCRC), sexual functioning, and associated quality of life (QoL), aiming to understand the comprehensive impact of EOCRC on these critical dimensions. Through an extensive search across PubMed, Scopus, and Embase up until November 2023, this study synthesized evidence from the literature while adhering to PRISMA guidelines. The studies included EOCRC patients under 50 years, which examined sexual functioning and QoL using validated instruments, and were published in English...
March 26, 2024: Diseases (Basel)
keyword
keyword
13798
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.